Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Clinical Oncology
  • Published:

The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone

British Journal of Cancer volume 78, pages 774–776 (1998)Cite this article

Abstract

Three out of four patients with primary (light chain) amyloid nephrotic syndrome treated with vincristine, doxorubicin and dexamethasone (VAD) induction obtained a partial response and are alive in continuing remission at 4.1, 6.5 and 9.3 years. These preliminary results are of considerable interest and suggest that prospective evaluation of this regimen is warranted in patients with this condition.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Christie Hospital, Manchester, Withington, UK

    AM Wardley

Authors
  1. AM Wardley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. GC Jayson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. DJ Goldsmith
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. MC Venning
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P Ackrill
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. JH Scarffe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wardley, A., Jayson, G., Goldsmith, D. et al. The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone. Br J Cancer 78, 774–776 (1998). https://doi.org/10.1038/bjc.1998.577

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1998.577

This article is cited by

Search

Advanced search

Quick links